Medtronic Statistics

Total Valuation

Medtronic has a market cap or net worth of EUR 102.64 billion. The enterprise value is 120.70 billion.

Market Cap	102.64B
Enterprise Value	120.70B

Important Dates

The next estimated earnings date is Tuesday, November 19, 2024.

Earnings Date	Nov 19, 2024
Ex-Dividend Date	Sep 27, 2024

Share Statistics

Shares Outstanding	n/a
Shares Change (YoY)	-0.88%
Shares Change (QoQ)	-2.18%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.28B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.53, with an EV/FCF ratio of 25.47.

EV / Earnings	33.37
EV / Sales	4.14
EV / EBITDA	14.53
EV / EBIT	21.16
EV / FCF	25.47

Financial Position

The company has a current ratio of 2.13, with a Debt / Equity ratio of 57.86.

Current Ratio	2.13
Quick Ratio	1.35
Debt / Equity	57.86
Debt / EBITDA	3.00
Debt / FCF	5.42
Interest Coverage	8.64

Financial Efficiency

Return on equity (ROE) is 7.95% and return on invested capital (ROIC) is 5.23%.

Return on Equity (ROE)	7.95%
Return on Assets (ROA)	4.41%
Return on Capital (ROIC)	5.23%
Revenue Per Employee	315,860
Profits Per Employee	38,075
Employee Count	95,000
Asset Turnover	0.36
Inventory Turnover	2.03

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +5.29% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+5.29%
50-Day Moving Average	77.63
200-Day Moving Average	76.92
Relative Strength Index (RSI)	49.71
Average Volume (20 Days)	874

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.91

Income Statement

In the last 12 months, Medtronic had revenue of EUR 30.01 billion and earned 3.62 billion in profits. Earnings per share was 2.73.

Revenue	30.01B
Gross Profit	19.66B
Operating Income	5.87B
Pretax Income	4.52B
Net Income	3.62B
EBITDA	8.30B
EBIT	5.87B
Earnings Per Share (EPS)	2.73

Full Income Statement

Balance Sheet

The company has 7.22 billion in cash and 25.67 billion in debt, giving a net cash position of -18.40 billion.

Cash & Cash Equivalents	7.22B
Total Debt	25.67B
Net Cash	-18.40B
Net Cash Per Share	n/a
Equity (Book Value)	44.36B
Book Value Per Share	34.44
Working Capital	10.74B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 6.35 billion and capital expenditures -1.61 billion, giving a free cash flow of 4.74 billion.

Operating Cash Flow	6.35B
Capital Expenditures	-1.61B
Free Cash Flow	4.74B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 65.52%, with operating and profit margins of 19.57% and 12.05%.

Gross Margin	65.52%
Operating Margin	19.57%
Pretax Margin	15.07%
Profit Margin	12.05%
EBITDA Margin	27.67%
EBIT Margin	19.57%
FCF Margin	15.79%

Dividends & Yields

Medtronic does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	-0.96%
Years of Dividend Growth	n/a
Payout Ratio	92.84%
Buyback Yield	0.88%
Shareholder Yield	0.88%
Earnings Yield	3.47%
FCF Yield	n/a

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Medtronic has an Altman Z-Score of 2.78. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.78
Piotroski F-Score	n/a